In Search to Replace Opioid Therapies for Chronic Pain

Several biotech companies are investing big money on the idea that they can develop drugs that can shut down the gene SCN9A. This gene functions are to produce pain-related protein called Nav1.7 and if SCN9A is shut down then you do not feel pain, but if the gene is working overtime in producing Nav1.7. you feel searing random pain. Read article here…..

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.